BioSpace News Archive

Regeneron Pharmaceuticals, Inc. and Checkmate Pharmaceuticals, Inc. a clinical stage biopharmaceutical company focused on proprietary technology to harness the power of the immune system to combat cancer, announced a definitive agreement for the acquisition of Checkmate by Regeneron at an all-cash price of $10.50 per share of Checkmate common stock.

BioXcel Therapeutics, Inc. announced strategic financing agreements with funds managed by Oaktree Capital Management, L.P. and Qatar Investment Authority.

CytoSorbents Corporation, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2022 operating and financial results after the market close on May 3, 2022.

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. today announced they have entered into a definitive merger agreement for a business combination that will result in Coeptis becoming a wholly-owned subsidiary of Bull Horn.

Neuraly today announced the completion of patient enrollment in its Phase 2 study of NLY01 for Parkinson’s disease (PD).

Miroculus, Inc. today announced the appointment of Mark Lewis as Executive Chairman.

Ncardia has launched a new business, Cellistic™, to focus Ncardia’s induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector.

Navidea Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance for the patent application titled, “Compounds And Compositions For Treating Leishmaniasis And Methods Of Diagnosis And Treating Using Same” (U.S. Patent Application No. 15/729,633).

Potrero Medical announced that the Accuryn Monitoring Solution will be showcased in presentations during the Society of Critical Care Medicine (SCCM) virtual meeting April 18-21, 2022.